These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 21094898

  • 1. K-cells and glucose-dependent insulinotropic polypeptide in health and disease.
    Cho YM, Kieffer TJ.
    Vitam Horm; 2010; 84():111-50. PubMed ID: 21094898
    [Abstract] [Full Text] [Related]

  • 2. Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide.
    Meier JJ, Nauck MA.
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):587-606. PubMed ID: 15533777
    [Abstract] [Full Text] [Related]

  • 3. Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders.
    Paschetta E, Hvalryg M, Musso G.
    Obes Rev; 2011 Oct; 12(10):813-28. PubMed ID: 21815989
    [Abstract] [Full Text] [Related]

  • 4. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).
    McIntosh CH, Widenmaier S, Kim SJ.
    Vitam Horm; 2009 Oct; 80():409-71. PubMed ID: 19251046
    [Abstract] [Full Text] [Related]

  • 5. Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue.
    Ugleholdt R.
    Dan Med Bull; 2011 Dec; 58(12):B4368. PubMed ID: 22142579
    [Abstract] [Full Text] [Related]

  • 6. Bombesin and nutrients independently and additively regulate hormone release from GIP/Ins cells.
    Li L, Wice BM.
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E208-15. PubMed ID: 15383372
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD, Gault VA, O'Harte FP, Flatt PR.
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [Abstract] [Full Text] [Related]

  • 8. What do we know about the secretion and degradation of incretin hormones?
    Deacon CF.
    Regul Pept; 2005 Jun 15; 128(2):117-24. PubMed ID: 15780431
    [Abstract] [Full Text] [Related]

  • 9. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM.
    Am J Physiol Endocrinol Metab; 2006 Mar 15; 290(3):E550-9. PubMed ID: 16219666
    [Abstract] [Full Text] [Related]

  • 10. Incretin hormone secretion over the day.
    Ahrén B, Carr RD, Deacon CF.
    Vitam Horm; 2010 Mar 15; 84():203-20. PubMed ID: 21094901
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of fat-induced gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide secretion from K cells.
    Yamane S, Harada N, Inagaki N.
    J Diabetes Investig; 2016 Apr 15; 7 Suppl 1(Suppl 1):20-6. PubMed ID: 27186351
    [Abstract] [Full Text] [Related]

  • 12. Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut.
    Fujita Y, Asadi A, Yang GK, Kwok YN, Kieffer TJ.
    Am J Physiol Gastrointest Liver Physiol; 2010 May 15; 298(5):G608-14. PubMed ID: 20185691
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of glucagon secretion.
    Young A.
    Adv Pharmacol; 2005 May 15; 52():151-71. PubMed ID: 16492545
    [Abstract] [Full Text] [Related]

  • 14. Mining incretin hormone pathways for novel therapies.
    Wideman RD, Kieffer TJ.
    Trends Endocrinol Metab; 2009 Aug 15; 20(6):280-6. PubMed ID: 19595611
    [Abstract] [Full Text] [Related]

  • 15. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May 15; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 16. Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
    Seino Y, Maekawa R, Ogata H, Hayashi Y.
    J Diabetes Investig; 2016 Apr 15; 7 Suppl 1(Suppl 1):27-32. PubMed ID: 27186352
    [Abstract] [Full Text] [Related]

  • 17. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G, Thomaseth K, Ahrén B.
    Metabolism; 2010 Jul 15; 59(7):988-92. PubMed ID: 20153002
    [Abstract] [Full Text] [Related]

  • 18. Fatty acid-binding protein 5 regulates diet-induced obesity via GIP secretion from enteroendocrine K cells in response to fat ingestion.
    Shibue K, Yamane S, Harada N, Hamasaki A, Suzuki K, Joo E, Iwasaki K, Nasteska D, Harada T, Hayashi Y, Adachi Y, Owada Y, Takayanagi R, Inagaki N.
    Am J Physiol Endocrinol Metab; 2015 Apr 01; 308(7):E583-91. PubMed ID: 25628425
    [Abstract] [Full Text] [Related]

  • 19. Incretin-based therapy and type 2 diabetes.
    Hare KJ, Knop FK.
    Vitam Horm; 2010 Apr 01; 84():389-413. PubMed ID: 21094909
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.